Cover Image

Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jonathan R. Treadwell, Ilya Ivlev, Benjamin Rouse, Nikhil K. Mull, Dawn C. Buse
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
by: Jonathan R. Treadwell, et al.
Published: (2025)

Disagreement with categorization of clinical trials included in Treadwell et al. systematic review and meta‐analysis
by: Rebecca Erwin Wells, et al.
Published: (2025)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
by: Nathaniel M. Schuster, et al.
Published: (2025)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
by: Dawn C. Buse, et al.
Published: (2024)

Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
by: Dawn C. Buse, et al.
Published: (2026)

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
by: Fred Cohen, et al.
Published: (2024)

Prevalence and burden of migraine in the United States: A systematic review
by: Fred Cohen, et al.
Published: (2024)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
by: Fred Cohen, et al.
Published: (2025)

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study
by: Dawn C. Buse, et al.
Published: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
by: Susan Hutchinson, et al.
Published: (2026)

Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study
by: Elizabeth K. Seng, et al.
Published: (2025)

Reviewer acknowledgment 2025
by: Jenn Vallimont
Published: (2026)

Response to “Optimizing triptan safety in emergency settings under cardiovascular risk uncertainty”
by: Ido Peles, et al.
Published: (2025)

Response to: Reassessing pediatric migraine disability: Toward an updated assessment tool in the era of novel therapeutics
by: Christina Murphy, et al.
Published: (2025)

A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine ( TEAM) study
by: Gregory A. Panza, et al.
Published: (2024)

Evaluating patient and family preferences for acute and preventive pediatric headache treatment
by: Elise G. Martin, et al.
Published: (2024)

Milk and plasma pharmacokinetics of single‐dose ubrogepant in healthy lactating women
by: Ramesh R. Boinpally, et al.
Published: (2025)

Redefining status migrainosus: A narrative review
by: Jennifer Robblee, et al.
Published: (2026)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
by: Marina Vives‐Mestres, et al.
Published: (2024)

Response to: Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays
by: Alicia Alpuente, et al.
Published: (2026)

Author Response to Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”
by: Ann I. Scher, et al.
Published: (2024)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
by: Richard B. Lipton, et al.
Published: (2025)

The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis
by: Rebecca Lindsay, et al.
Published: (2024)

Response to Letter to the Editor regarding “Calcitonin gene‐related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme‐linked immunosorbent assays”
by: Michael L. Garelja, et al.
Published: (2026)

When smoke clouds the mind: Exploring the headache consequences of the 2023 Canadian wildfires
by: Fred Cohen, et al.
Published: (2025)

Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study
by: Alexis Espanioli, et al.
Published: (2025)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
by: Bilal Ahmed Rizvi, et al.
Published: (2024)

IV dexamethasone as adjuvant therapy to metoclopramide for acute posttraumatic headache in the ED : A randomized controlled trial
by: Kareem Joudi, et al.
Published: (2026)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
by: Richard B. Lipton, et al.
Published: (2025)

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
by: Jennifer Robblee, et al.
Published: (2025)

A phase 1 study of the breast milk and plasma pharmacokinetics of zavegepant 10 mg intranasal dose in healthy lactating women
by: Abhijeet Jakate, et al.
Published: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
by: Jessica Ailani, et al.
Published: (2024)

Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial
by: Serena Laura Orr, et al.
Published: (2024)

Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral pharmacotherapies
by: Jennifer Robblee, et al.
Published: (2024)

The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
by: Jennifer Robblee, et al.
Published: (2024)

The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis
by: Scott W. Kirkland, et al.
Published: (2024)

Patient perspectives on research gaps in cluster headache
by: Faraidoon Haghdoost, et al.
Published: (2026)

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
by: Maggie R. Mittleman, et al.
Published: (2024)

Sex‐specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross‐sectional evaluation in ELSA ‐Brasil study
by: Arão Belitardo de Oliveira, et al.
Published: (2025)